Stanley W. Peters III - 25 Feb 2022 Form 4 Insider Report for CONMED Corp (CNMD)

Role
VP GM Advanced Surgery
Signature
/s/ Sarah M. Oliker for Stanley W. Peters III by Power of Attorney
Issuer symbol
CNMD
Transactions as of
25 Feb 2022
Net transactions value
-$1,144,947
Form type
4
Filing time
28 Feb 2022, 16:05:54 UTC
Previous filing
09 Feb 2022
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CNMD Common Stock Options Exercise $107,649 +2,700 +4286% $39.87 2,763 25 Feb 2022 Direct
transaction CNMD Common Stock Sale $399,600 -2,700 -98% $148.00 63 25 Feb 2022 Direct
transaction CNMD Common Stock Options Exercise $335,440 +8,000 +12698% $41.93 8,063 25 Feb 2022 Direct
transaction CNMD Common Stock Sale $952,155 -6,418 -80% $148.36 1,645 25 Feb 2022 Direct F1
transaction CNMD Common Stock Sale $236,281 -1,582 -96% $149.36 63 25 Feb 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -2,700 -100% $0.000000* 0 25 Feb 2022 Common Stock 2,700 $39.87 Direct F3
transaction CNMD Options To Purchase Common Stock Options Exercise $0 -8,000 -24% $0.000000 25,000 25 Feb 2022 Common Stock 8,000 $41.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.00 to $148.93. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.04 to $149.80. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.
F3 The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.